FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    33081000077110 un fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    un Is a General adjectival modifier false Inferred relationship Some
    un Is a nombre false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Aspirin 500 mg and hydrocodone bitartrate 5 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Aspirin 325 mg and meprobamate 200 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Aspirin 325 mg and meprobamate 200 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Aspirin 325 mg and methocarbamol 400 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Aspirin 325 mg and methocarbamol 400 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely aspirin 325 milligram and oxycodone hydrochloride 2.25 milligram and oxycodone terephthalate 190 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely aspirin 325 milligram and oxycodone hydrochloride 2.25 milligram and oxycodone terephthalate 190 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely aspirin 325 milligram and oxycodone hydrochloride 2.25 milligram and oxycodone terephthalate 190 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 3
    Aspirin 325 mg and oxycodone hydrochloride 4.5 mg and oxycodone terephthalate 380 microgram oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Aspirin 325 mg and oxycodone hydrochloride 4.5 mg and oxycodone terephthalate 380 microgram oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Aspirin 325 mg and oxycodone hydrochloride 4.5 mg and oxycodone terephthalate 380 microgram oral tablet Has presentation strength denominator value False un Inferred relationship Some 3
    Atenolol 100 mg and chlortalidone 25 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Atenolol 100 mg and chlortalidone 25 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Atenolol 50 mg and chlortalidone 25 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Atenolol 50 mg and chlortalidone 25 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely atropine 25 microgram and difenoxin hydrochloride 1 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely atropine 25 microgram and difenoxin hydrochloride 1 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 3
    Azatadine maleate 1 mg and pseudoephedrine sulfate 120 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Azatadine maleate 1 mg and pseudoephedrine sulfate 120 mg oral tablet Has presentation strength numerator value False un Inferred relationship Some 2
    Azatadine maleate 1 mg and pseudoephedrine sulfate 120 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 3
    Benazepril hydrochloride 10 mg and hydrochlorothiazide 12.5 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Benazepril hydrochloride 10 mg and hydrochlorothiazide 12.5 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely brompheniramine 12 milligram and pseudoephedrine hydrochloride 120 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely brompheniramine 12 milligram and pseudoephedrine hydrochloride 120 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely brompheniramine 6 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely brompheniramine 6 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Captopril 25 mg and hydrochlorothiazide 15 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Captopril 25 mg and hydrochlorothiazide 15 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Captopril 25 mg and hydrochlorothiazide 25 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Captopril 25 mg and hydrochlorothiazide 25 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Captopril 50 mg and hydrochlorothiazide 15 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Captopril 50 mg and hydrochlorothiazide 15 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Chlordiazepoxide hydrochloride 5 mg and clidinium bromide 2.5 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Chlordiazepoxide hydrochloride 5 mg and clidinium bromide 2.5 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 2
    Chlorothiazide 250 mg and methyldopa 250 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Chlorothiazide 250 mg and methyldopa 250 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Chlorothiazide 250 mg and reserpine 125 microgram oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Chlorothiazide 250 mg and reserpine 125 microgram oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely chlorothiazide 500 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Homatropine methylbromide 1.5 mg and hydrocodone bitartrate 5 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Homatropine methylbromide 1.5 mg and hydrocodone bitartrate 5 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet Has presentation strength denominator value False un Inferred relationship Some 3
    Product containing precisely hydralazine hydrochloride 100 milligram and hydrochlorothiazide 50 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely hydralazine hydrochloride 100 milligram and hydrochlorothiazide 50 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely hydralazine hydrochloride 25 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely hydralazine hydrochloride 25 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Acrivastine 8 mg and pseudoephedrine hydrochloride 60 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Acrivastine 8 mg and pseudoephedrine hydrochloride 60 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely methenamine mandelate 500 milligram and monobasic sodium phosphate 500 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely methenamine mandelate 500 milligram and monobasic sodium phosphate 500 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Methscopolamine 2.5 mg and pseudoephedrine hydrochloride 120 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Methscopolamine 2.5 mg and pseudoephedrine hydrochloride 120 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Methyclothiazide 2.5 mg and reserpine 100 microgram oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely nitrofurantoin macrocrystal 25 milligram and nitrofurantoin monohydrate 75 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely nitrofurantoin macrocrystal 25 milligram and nitrofurantoin monohydrate 75 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Amiloride hydrochloride 5 mg and hydrochlorothiazide 50 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Amiloride hydrochloride 5 mg and hydrochlorothiazide 50 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely amitriptyline hydrochloride 12.5 milligram and chlordiazepoxide 5 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely amitriptyline hydrochloride 12.5 milligram and chlordiazepoxide 5 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely amitriptyline 10 milligram and perphenazine 4 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely amitriptyline 10 milligram and perphenazine 4 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely amlodipine besilate 2.5 milligram and benazepril hydrochloride 10 milligram/1 each conventional release oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely amlodipine besilate 2.5 milligram and benazepril hydrochloride 10 milligram/1 each conventional release oral capsule Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely amlodipine besilate 5 milligram and benazepril hydrochloride 10 milligram/1 each conventional release oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely amlodipine besilate 5 milligram and benazepril hydrochloride 10 milligram/1 each conventional release oral capsule Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely amlodipine besilate 5 milligram and benazepril hydrochloride 20 milligram/1 each conventional release oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely amlodipine besilate 5 milligram and benazepril hydrochloride 20 milligram/1 each conventional release oral capsule Has presentation strength denominator value False un Inferred relationship Some 2
    Amobarbital sodium 50 mg and secobarbital sodium 50 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Amobarbital sodium 50 mg and secobarbital sodium 50 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 2
    Olmesartan medoxomil 5 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Olmesartan medoxomil 20 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Olmesartan medoxomil 40 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Nitisinone 2 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely nitisinone 5 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Nitisinone 10 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 1

    Start Previous Page 8 of 215 Next End

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start